Abstract Background The relationship between the methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphism (SNP) and serum homocysteine (Hcy) levels or H-type hypertension in different populations is inconsistent. This study aimed to explore the association between the MTHFR rs1801133 SNP and serum Hcy levels of Zhuang hypertensive patients in the central region of Guangxi. Methods A total of 606 Zhuang inpatients with essential hypertension were recruited in our hospital from August 2016 to December 2018. The patients were divided into H-type hypertension (Hcy > 10 µmol/L, n = 528) and non–H-type hypertension (Hcy ≤ 10 µmol/L, n = 78) groups. At the same time, an age- and sex-matched group of 379 subjects with normal physi...
Background: Plasma level of total homocysteine (tHcy) is negatively correlated with kidney function ...
Background: An increased serum total homocysteine (tHcy) concentration is typically associated with ...
Background: Hyperhomocysteinemia is a risk factor for cardiovascular disease. To date, limited prosp...
Background: Hypertension (HTN), dyslipidemia and hyperhomocysteinemia (HHcy) are risk factors for ca...
Objective. Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme of homocysteine metabolism an...
Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and...
Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and...
Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and...
Objective To examine the relationship between occurrence of hyperlipidemia. plasma homocysteine and ...
Abstract Background H type hypertension is defined as homocysteine (Hcy) ≥ 10 μmol/L in combination ...
To examine the relationship between occurrence of hyperlipidemia, plasma homocysteine and polymorphi...
BackgroundThromboembolic disease is a major cause of morbidity and mortality in many countries. Our ...
Objective: To evaluate the performance of methylenetetrahydrofolate reductase (MTHFR) gene C677T pol...
Thromboembolic disease is a major cause of morbidity and mortality in many countries. Our previous s...
Previous studies found that hypertension and high homocysteine (HHcy) exhibited a synergistic effect...
Background: Plasma level of total homocysteine (tHcy) is negatively correlated with kidney function ...
Background: An increased serum total homocysteine (tHcy) concentration is typically associated with ...
Background: Hyperhomocysteinemia is a risk factor for cardiovascular disease. To date, limited prosp...
Background: Hypertension (HTN), dyslipidemia and hyperhomocysteinemia (HHcy) are risk factors for ca...
Objective. Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme of homocysteine metabolism an...
Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and...
Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and...
Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and...
Objective To examine the relationship between occurrence of hyperlipidemia. plasma homocysteine and ...
Abstract Background H type hypertension is defined as homocysteine (Hcy) ≥ 10 μmol/L in combination ...
To examine the relationship between occurrence of hyperlipidemia, plasma homocysteine and polymorphi...
BackgroundThromboembolic disease is a major cause of morbidity and mortality in many countries. Our ...
Objective: To evaluate the performance of methylenetetrahydrofolate reductase (MTHFR) gene C677T pol...
Thromboembolic disease is a major cause of morbidity and mortality in many countries. Our previous s...
Previous studies found that hypertension and high homocysteine (HHcy) exhibited a synergistic effect...
Background: Plasma level of total homocysteine (tHcy) is negatively correlated with kidney function ...
Background: An increased serum total homocysteine (tHcy) concentration is typically associated with ...
Background: Hyperhomocysteinemia is a risk factor for cardiovascular disease. To date, limited prosp...